Effect of Peroxisome Proliferator-Activated Receptor Agonists on Serum Inflammatory Markers in Diabetic Rats
Background: Inflammation had a key role in several pathological conditions including atherosclerosis. Previous studies indicated that the proxisome proliferator-activated receptors (PPAR) are involved in numerous physiological and pathological conditions. The aim of this study was to investigate the...
Main Authors: | Majid Khazaei, Zoya Tahergorabi, Ensieh Salehi |
---|---|
Format: | Article |
Language: | fas |
Published: |
Isfahan University of Medical Sciences
2014-05-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/3250 |
Similar Items
-
Evaluation of serum interleukin-1 beta as an inflammatory marker in COPD patients
by: Dina R. Hammad, et al.
Published: (2015-04-01) -
Discovery Of Peroxisome
Proliferator-Activated Receptor
Gamma Agonist
by: Lee, Guan Sheng
Published: (2013) -
Assessment of Serum Interleukin-2, -4 and C-reactive protein Levels in patients with Giardiasis and Cryptosporidiosis
by: Mohammed J. Shakir, et al.
Published: (2014-10-01) -
Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021-10-01) -
Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids
by: Michael Heming, et al.
Published: (2018-05-01)